Jul 12, 2021
1:1550
For every 1550 shares held, investors received 1. The price per share adjusted from $0.01 to $0.00.
The split itself did not change the total investment value.
PharmaCyte Biotech, Inc. (PMCB) trades on the NASDAQ Capital Market in the Biotechnology industry.
PharmaCyte Biotech, Inc. company overviewThe latest split shown was on July 12, 2021. It was a 1-for-1550 reverse split, so shareholders received 1 share for every 1550 they held.
This history records 2 splits between December 8, 2003 and July 12, 2021.